Fieldpoint Private Securities’s Acceleron Pharma XLRN Stock Holding History

Fieldpoint Private Securities’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-973	Closed	-$167K	–	1771
2021 Q3	$167K	Hold	973	–	–	0.04%	341
2021 Q2	$121K	Sell	973 -12	-1%	-$1.51K	0.03%	385
2021 Q1	$134K	Sell	985 -287	-23%	-$37.1K	0.03%	354
2020 Q4	$163K	Buy	+1,272	New	+$149K	0.04%	317

Fieldpoint Private Securities's XLRN Position: Q4 2021 in Review

Fieldpoint Private Securities sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 973 shares — an estimated $167K sold.

Fieldpoint Private Securities first reported a position in XLRN in Q4 2020 and held it in 4 quarters. The position peaked at $167K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Fieldpoint Private Securities reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Fieldpoint Private Securities sold 973 Acceleron Pharma shares in Q4 2021, an estimated $167K.
Fieldpoint Private Securities first reported a position in Acceleron Pharma in Q4 2020 and held it in 4 quarters.
Fieldpoint Private Securities's Acceleron Pharma position peaked at $167K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Fieldpoint Private Securities's 13F filing for Q4 2021, filed 24 Jan 2022.